On Monday, vaccine manufacturer Moderna announced that – according to a study – their vaccine is effective against both the British and the South African virus mutations.
Recently, virus variants from the United Kingdom and South Africa that are more contagious than the regular coronavirus have caused concern.
Now, scientists from the US pharmaceutical company say that Moderna’s corona vaccine appears to work against the new variants of the pandemic virus.
“We are excited about this new data, which strengthens our confidence that Moderna’s COVID-19 vaccine will protect against these newly discovered variants,” Moderna CEO Stephane Bancel noted.
New version of the vaccine
Nevertheless, the company is developing a new version of the vaccine that can be used as an enhancer.
“We’re doing it to be in front of the curve if necessary,” Moderna’s Tal Zaks said, according to the New York Times.
In the study, researchers looked at blood samples taken from eight people who had received the recommended two doses of the Moderna vaccine.
The findings are yet to be peer-reviewed, but they suggest immunity from the corona vaccine works against the new variants.
Source: #Norway Today, #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com